152 results
8-K
EX-99.1
NTLA
Intellia Therapeutics Inc
9 May 24
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:40am
”) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express
8-K
EX-99.1
NTLA
Intellia Therapeutics Inc
15 Apr 24
Departure of Directors or Certain Officers
4:21pm
” or the “Company”) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited
8-K
5vcblb8wcc
22 Mar 24
Termination of a Material Definitive Agreement
9:26am
424B5
a0llk2q
26 Feb 24
Prospectus supplement for primary offering
7:04am
424B5
y5ko12
23 Feb 24
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
814ltzel4t6pvdafsteb
22 Feb 24
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
EX-99.1
i08x9wgmdm8c1g1oq
1 Feb 24
Regulation FD Disclosure
4:05pm
8-K
ci4cja 75enjd0m
4 Jan 24
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
4:07pm
8-K
EX-99.1
jlu72co6r
4 Jan 24
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
4:07pm
8-K
EX-99.1
mgm8dtsy
9 Nov 23
Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
EX-99.1
ldz5f 7iaf
2 Nov 23
Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting
7:11am
8-K
nurftbq
2 Nov 23
Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting
7:11am
8-K
flff8t9ppfr edr2
18 Oct 23
Intellia Therapeutics Announces FDA Clearance of
7:30am
8-K
EX-99.1
da1y779rb5o6r6
18 Oct 23
Intellia Therapeutics Announces FDA Clearance of
7:30am
8-K
3hoc1j7d
3 Oct 23
Regeneron and Intellia Announce Expanded Research Collaboration
7:19am